Objective
This annual conference will bring legal practitioners working with
the pharmaceutical sector up-to-date on the latest relevant regulatory
developments, legislative initiatives and case law. A particular focus
will be on implications for the sector of recent EU activities in the
fields of competition and patent law and of pharmaceutical law, in
particular the ongoing EU initiatives on early and equal access to
medicines.
Key topics
Competition law and patent law
- Consequences of the recent CJEU judgment in Genentech v Hoescht (C-567/14) on non-exclusive licence agreements
- Lessons learned from the General Court ruling Lünbeck on “pay for delays”
- Outcome of recent CJEU and national rulings on patent term extensions for pharmaceutical products
Early and equal access to medicines in the EU
- Ongoing strategy for EU cooperation on Health Technology Assessment
- Recent initiatives from the EMA on early access to medicines: STAMP, PRIME, adaptive pathways, joint scientific advice
EU pharmaceutical law round-up
- Update on recent activities of the European Commission
- Adoption of the EU reform on medical devices and in-vitro diagnostics
- Result of the public consultation on the concept of similarity for orphan designations
- Impact of Brexit in the pharmaceutical sector
- e-Health and patient‘s data
Who should attend?
In-house counsel and legal or patent advisers in pharmaceutical
companies; lawyers in private practice dealing with pharmaceuticals and
medical devices; lawyers in national ministries and authorities dealing
with regulation of the sector.
Gebühren in €:
|
Standard
|
EU und ERA Mitstifter
|
Junge Juristen und andere Gruppen
|
|
Registrierung
|
|
|
|
|
|
Mehr Informationen zu den Vergünstigungen
Frühzeitige Anmeldungen
10 % bis 23.01.2017
Mögliche Ermässigungen
25 % - Für junge Juristen bis einschließlich 30 Jahre (wichtig: bitte Kopie des Personalausweises mitschicken); hauptberufliche Mitarbeiter von Universitäten oder vergleichbaren wissenschaftlichen Einrichtungen; Mitarbeiter karitativer Organisationen
40 % - Für Beschäftigte der EU;
für Beschäftigte von Mitstiftern der ERA (Bulgarien, Dänemark, Deutschland und die deutschen Länder, Finnland, Frankreich, Griechenland, Irland, Italien, Kroatien, Lettland, Litauen, Luxemburg, Malta, Niederlande, Österreich, Polen, Portugal, Rumänien, Schottland, Schweden, Slowenien, Slowakei, Spanien, Tschechien, Ungarn, Vereinigtes Königreich, Zypern, Stadt Trier)
40 % - Fellows des European Law Institute